Table 3.
Laboratory Tests | Study Group Mean ± SD |
Control Group Mean ± SD |
p-Value |
---|---|---|---|
WBC (n) | 6.4 ± 0.97 | 7.8 ± 2.34 | 0.008 |
RBC (n) | 4.4 ± 0.50 | 4.4 ± 0.47 | 0.066 |
Neutrophils (%) | 70.2 ± 8.27 | 64.2 ± 9.09 | 0.011 |
Lymphocytes (%) | 17.9 ± 6.39 | 23.6 ± 8.02 | 0.003 |
CK (U/L) | 147.6 ± 79.41 | 101.9 ± 83.02 | 0.035 |
CK-MB (U/L) | 19.7 ± 4.55 | 22.0 ± 11.05 | 0.307 |
CRP (mg/L) | 32.8 ± 19.07 | 16.2 ± 10.26 | 0.005 |
Fibrinogen (mg/L) | 511.4 ± 120.59 | 435.8 ± 112.93 | 0.016 |
ESR (mm/h) | 48.0 ± 11.34 | 31.0 ± 11.15 | 0.001 |
Glycemia (mg/dL) | 145 ± 84.94 | 115.8± 35.40 | 0.084 |
Hba1c (%) | 6.3 ± 1.19 | 6.5 ± 1.17 | 0.433 |
Creatinine (mg/dL) | 0.9 ± 0.24 | 0.9 ± 0.31 | 0.527 |
Urea (mg/dL) | 45.4 ± 13.76 | 41.3 ± 13.62 | 0.264 |
Normal ranges (laboratory reference values): RBC, 4.5–5.9 × 106/μL; WBC, 4–9.5 × 103/μL; neutrophil percentage, 45–70%; lymphocyte percentage, 20–40%; ESR, 0–15 mm/h; CRP, 0–10 mg/L; fibrinogen, 200–393 mg/dL; CK, 30–170 U/L; CK-MB, 0–16 U/L; glycemia, 74–106 mg/dL; Hba1c, normal range 4–5.6%, prediabetes, 5.7–6.4%, diabetes, >6.5%; creatinine, 0.7–1.3 mg/dL men and 0.6–1.1 mg/dL women; urea, 15–45 mg/dL.